CIK 0000812796 · Non-accelerated filer<br>Smaller reporting company
SOLIGENIX, INC.
Sign in to watch- Ticker
- SNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 411505029
- Phone
- 609-538-8200
- Business address
- 29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
- Former names
- SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Other events
- 8-K Event Delisting notice
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- 10-K Report Annual Report
- 8-K Event Delisting notice
- 8-K Event Other events
- 8-K Event Shareholder rights changed · Executive or director change · Bylaws or fiscal year change · Shareholder vote results · Regulation FD disclosure
- DEFA14A Proxy Proxy Materials
- 8-K Event Other events
- DEF 14A Proxy Proxy Statement
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Regulation FD disclosure
- 8-A12G Other 8-A12G
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Delisting notice
- 8-K Event Other events
- 8-K Event Other events
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 11 of 72 · 1,429 filings